MSCI
MSCI
$560.63
-0.44%
MSCI, Inc. is a leading provider of critical decision support tools and services for the global investment community, operating primarily in the financial data and stock exchanges industry. The company's core offerings include equity, fixed income, and real estate indexes, portfolio analytics, and ESG and climate data, with over $18 trillion in benchmarked assets and $2.3 trillion in ETF assets linked to its indexes. MSCI is a dominant player in the index and analytics space, distinguished by its mission to enable investors to build better portfolios and its expansive data and analytics ecosystem. The current investor narrative centers on the company's robust revenue growth, driven by its index and analytics segments, alongside concerns about its valuation and the impact of market volatility on its subscription-based model, as evidenced by recent price fluctuations and analyst attention on its growth trajectory.…
MSCI
MSCI
$560.63
Related headlines
Investment Opinion: Should I buy MSCI Today?
Rating: Buy. MSCI is a high-quality growth company with a dominant market position, strong revenue growth, and exceptional profitability. The analyst consensus is Strong Buy with an average target of $692.06, implying 21.2% upside. The thesis is supported by 14% revenue growth, 83% gross margin, and a forward PE of 25.37x, which is reasonable given expected earnings growth of ~45%.
Sign up to view all
MSCI 12-Month Price Forecast
MSCI's strong fundamentals, including high margins and robust growth, support a bullish stance. The valuation is reasonable given expected earnings growth, and analyst sentiment is overwhelmingly positive. However, the high leverage and market sensitivity warrant a medium confidence. If revenue growth accelerates above 15% or the stock pulls back to below $520, the stance would be upgraded to high confidence. Conversely, if growth decelerates below 10% or the market enters a prolonged downturn, the stance would be downgraded to neutral.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on MSCI's 12-month outlook, with a consensus price target around $692.06 and implied upside of +23.4% versus the current price.
Average Target
$692.06
0 analysts
Implied Upside
+23.4%
vs. current price
Analyst Count
—
covering this stock
Price Range
$570 - $760
Analyst target range
MSCI is covered by 17 analysts, with a consensus recommendation of 'Strong Buy' (mean rating of 1.5). The average target price is $692.06, implying an upside of approximately 21.2% from the current price of $570.76. The analyst sentiment is overwhelmingly bullish, with no sell ratings and a majority of buy or overweight ratings. The target price range is $570.00 to $760.00, with the low end near the current price, suggesting limited downside risk, while the high end implies a 33.2% upside. The wide spread between low and high targets indicates moderate uncertainty, but the recent upgrades from firms like Wells Fargo (from Equal Weight to Overweight) and the strong buy ratings from Raymond James and others reinforce the positive outlook. This bullish consensus reflects confidence in MSCI's growth drivers, including its index and analytics segments, and its ability to maintain high margins.
Bulls vs Bears: MSCI Investment Factors
MSCI presents a compelling growth story with strong revenue growth, exceptional margins, and a dominant market position. The bull case is supported by a 14% revenue growth, 83% gross margin, and a Strong Buy consensus with 21% upside. However, the bear case highlights a rich valuation (PS 14.12x), high leverage, and recent price underperformance. Currently, the bull case has stronger evidence given the company's fundamental strength and analyst confidence, but the key tension is whether the premium valuation can be sustained. If growth decelerates or market volatility persists, the stock could face significant multiple compression, making the valuation the most critical factor to watch.
Bullish
- Strong Revenue Growth: MSCI's Q1 2026 revenue grew 14.07% YoY to $850.8M, with consistent sequential growth from $745.8M in Q1 2025. This growth is driven by the Index segment, which contributed $496.3M, and reflects robust demand for its benchmarking and analytics services.
- Exceptional Profitability: Gross margin stands at 83.33% and operating margin at 54.67% in Q1 2026, showcasing an asset-light, high-margin business model. Net margin improved to 47.72% from 38.70% a year ago, indicating expanding profitability and operational leverage.
- Analyst Strong Buy Consensus: With 17 analysts, the consensus is 'Strong Buy' (mean rating 1.5), and the average target price of $692.06 implies 21.2% upside from the current price of $570.76. No sell ratings and recent upgrades (e.g., Wells Fargo) reinforce bullish sentiment.
- Undervalued vs. Historical PE: The trailing PE of 36.82x is near the lower end of its 5-year range (24.32x-73.83x), suggesting the stock may be undervalued relative to its own history. The forward PE of 25.37x implies expected earnings growth of ~45%, aligning with its growth trajectory.
Bearish
- High Valuation Premium: MSCI trades at a PS ratio of 14.12x and EV/EBITDA of 25.93x, significantly above industry averages. This premium leaves little room for error; any growth deceleration could trigger multiple compression and significant downside.
- Leveraged Balance Sheet: Debt-to-equity is -2.39 due to negative equity from aggressive buybacks, and the current ratio is 0.90, indicating liquidity pressure. High leverage increases financial risk, especially if interest rates remain elevated or cash flows weaken.
- Recent Price Weakness: The stock has fallen 9.6% over the past 3 months and underperformed the S&P 500 by 11.3% over the same period. The recent drop from $644.77 high to $570.76 suggests momentum is negative, and technical support at $501.08 could be tested.
- Negative ROE and Buyback Concerns: ROE is -45.29% due to negative equity, a result of extensive share buybacks. While buybacks boost EPS, they increase financial leverage and reduce the equity buffer, making the company more vulnerable to downturns.
MSCI Technical Analysis
MSCI's stock has exhibited a volatile yet upward long-term trend, with a 1-year price change of +38.87%, though it has recently pulled back from its highs. The current price of $570.76 sits at approximately 88.5% of its 52-week range (between $501.08 and $644.77), indicating it is trading closer to the upper end but has retreated from the peak. This positioning suggests the stock has strong momentum but is currently in a corrective phase, potentially offering a buying opportunity if support holds, or signaling further downside if the correction deepens.
Beta
1.22
1.22x market volatility
Max Drawdown
-18.1%
Largest decline past year
52-Week Range
$501-$645
Price range past year
Annual Return
+1.2%
Cumulative gain past year
| Period | MSCI Return | S&P 500 |
|---|---|---|
| 1m | -2.4% | +1.0% |
| 3m | -9.4% | +1.1% |
| 6m | -1.5% | +13.8% |
| 1y | +1.2% | +19.5% |
| ytd | -0.8% | +12.2% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
MSCI Fundamental Analysis
MSCI's revenue trajectory remains robust, with the most recent quarter (Q1 2026) reporting revenue of $850.8 million, a 14.07% year-over-year increase. This growth is consistent with the multi-quarter trend, as revenue has grown from $745.8 million in Q1 2025 to $850.8 million in Q1 2026, with sequential increases in each quarter. The Index segment is the primary growth driver, contributing $496.3 million in Q1 2026, followed by Analytics at $190.0 million, while ESG and Climate and other segments add $91.9 million and $72.6 million, respectively. The company's profitability is exceptional, with a gross margin of 83.33% and an operating margin of 54.67% in Q1 2026, reflecting its asset-light, high-margin business model. Net income for the quarter was $406.0 million, a net margin of 47.72%, which is a significant improvement from the 38.70% net margin in Q1 2025, indicating expanding profitability. MSCI's balance sheet is highly leveraged, with a debt-to-equity ratio of -2.39 (due to negative equity from buybacks), but it generates substantial free cash flow of $1.54 billion TTM, which covers its debt obligations and dividends. The company's ROE is negative (-45.29%) due to the negative equity, but its ROA of 21.13% demonstrates strong asset efficiency, and its current ratio of 0.90 suggests adequate liquidity despite the leverage.
Quarterly Revenue
$850800000.0B
2026-03
Revenue YoY Growth
+14.1%
YoY Comparison
Gross Margin
83.3%
Latest Quarter
Free Cash Flow
$1.5B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is MSCI Overvalued?
Given MSCI's positive net income, the PE ratio is the primary valuation metric. The trailing PE is 36.82x, while the forward PE is 25.37x, indicating the market expects significant earnings growth. The gap between trailing and forward PE implies an expected earnings increase of approximately 45%, which aligns with the company's strong growth trajectory. MSCI's valuation is at a premium to the broader market, with a PS ratio of 14.12x and an EV/EBITDA of 25.93x, reflecting its high growth and profitability. Compared to industry averages, MSCI trades at a substantial premium, justified by its superior margins and growth. Historically, the stock's PE has ranged from 24.32x to 73.83x over the past five years, and the current trailing PE of 36.82x is near the lower end of that range, suggesting the stock may be undervalued relative to its own history, especially considering its growth prospects.
PE
36.8x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 33x~47x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
25.9x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: MSCI's balance sheet is highly leveraged, with a debt-to-equity ratio of -2.39 due to negative equity from aggressive buybacks. This leverage increases financial risk, especially if interest rates remain high or cash flows decline. The current ratio of 0.90 indicates potential liquidity constraints, though the company generates substantial free cash flow of $1.54 billion TTM, which helps service debt. Revenue concentration in the Index segment (58% of Q1 2026 revenue) exposes the company to market volatility, as index-linked fees depend on asset values and trading activity. Additionally, the negative ROE of -45.29% reflects the impact of buybacks on equity, which could be a concern for investors focused on return metrics.
FAQ
The key risks include: 1) Valuation risk - trading at a high PS ratio of 14.12x, any growth deceleration could lead to multiple compression. 2) Financial risk - high leverage with a debt-to-equity of -2.39 and current ratio of 0.90, increasing vulnerability to interest rate hikes. 3) Market risk - beta of 1.222 means the stock is more volatile than the market, and a downturn could reduce revenue. 4) Competitive risk - low-cost index providers could pressure pricing. The most severe risk is a prolonged market downturn, which could push the stock down 12% to the 52-week low.
Analysts have a Strong Buy consensus with an average target of $692.06, implying 21.2% upside. In the base case (50% probability), the stock could reach $620-$692 in 12 months. In the bull case (30% probability), it could hit $650-$760, driven by strong growth. In the bear case (20% probability), it could fall to $501-$570 if market conditions deteriorate. The most likely scenario is the base case, assuming revenue growth continues at 14% and margins remain stable.
MSCI is trading at a premium to the broader market, with a trailing PE of 36.82x and a PS ratio of 14.12x. However, compared to its own history, the current PE is near the lower end of its 5-year range (24.32x-73.83x), suggesting it may be undervalued relative to its growth prospects. The forward PE of 25.37x implies the market expects significant earnings growth, which is justified by the company's 14% revenue growth and expanding margins. Overall, MSCI is fairly valued for its growth and profitability, but investors are paying a premium for quality.
MSCI is a good buy for investors seeking a high-quality growth stock with strong fundamentals. The analyst consensus is Strong Buy with an average target of $692.06, implying 21.2% upside from the current price of $570.76. The company's revenue growth of 14% and gross margin of 83% provide a solid foundation. However, the stock is not cheap, trading at a forward PE of 25.37x, so it may not suit value investors. For growth-oriented investors with a medium-term horizon, MSCI offers a favorable risk/reward, but they should be prepared for volatility given its beta of 1.22.
MSCI is best suited for long-term investment due to its strong growth trajectory, high margins, and dominant market position. The company's recurring revenue model and exposure to secular trends like ESG investing provide visibility for multi-year growth. With a beta of 1.222, the stock is volatile in the short term, making it less suitable for short-term trading. A minimum holding period of 3-5 years is recommended to ride out market cycles and benefit from earnings growth. The dividend yield of 1.26% adds a modest income component, but the primary return driver is capital appreciation.